查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662896

髓內釘市場預測至 2030 年：按產品類型、材料類型、年齡層、骨折類型、分銷管道、最終用戶和地區進行的全球分析

Intramedullary Nails Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Age Group, Fracture Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球髓內釘市值為 7.673 億美元，預計到 2030 年將達到 11.387 億美元，預測期內的複合年成長率為 6.8%。

髓內釘是用於穩定骨折的整形外科植入。它被插入骨的髓管（空心中心），以便在癒合過程中對齊和支撐骨碎片；這提供了內部固定。它們通常用於治療股骨、脛骨和肱骨骨折，並具有多種設計和材質（鈦、不銹鋼），以滿足骨折類型和患者的需求。允許早期活動並減少外固定的需要。

根據世界衛生組織 (WHO) 的數據，道路交通傷害是全球造成殘疾和死亡的沉重負擔，每年約有 119 萬人因此死亡。

老化與骨質疏鬆症

全球人口老化，特別是60歲以上人口的老化是髓內釘市場的主要動力。骨質疏鬆症等疾病會增加骨折的風險，需要先進的整形外科解決方案。預計2050年老齡人口將達21億，髓內釘需求將大幅增加。這些裝置提供有效的骨折管理，允許更快的恢復和改善活動能力，這對老年患者來說很重要。

植入高成本

髓內釘的高價是市場成長的一大障礙，尤其是在新興市場。儘管這些植入很有效，但對於許多患者來說，它們的價格太昂貴，限制了他們接受可能挽救生命的手術的機會。這種影響也延伸到醫療保健提供者和設施，在因成本而無法獲得最佳護理的情況下，會導致患者康復時間更長、治療效果更差。

客製化髓內釘的開發

生物分解性的指甲、內建感測器的智慧指甲和改進的鎖定機制等設計和材料方面的技術進步正在改善治療效果並擴大可有效治療的疾病範圍。那些專注於研發並向市場推出創新產品的公司能夠脫穎而出並佔據更大的市場佔有率。

醫療報銷政策變化

報銷限制可能導致治療量減少並阻礙市場擴張，尤其是在醫療預算有限的地區。髓內釘手術的報銷率不足和保險覆蓋範圍限制給患者和提供者帶來了財務障礙。社會經濟差異，包括獲得醫療保健、教育和資源的差異，會影響對整形外科護理的需求。

COVID-19 的影響

疫情對髓內釘市場產生了較大影響，新冠肺炎疫情尖峰時段手術量較疫情前下降了44.6%。選擇性手術延後或取消，造成大量積壓病例。雖然在高峰過後，手術量已恢復到疫情前水準的 85.8%，但清理積壓手術所帶來的預期激增尚未實現。

鈦合金市場預計將成為預測期內最大的市場

由於鈦合金具有強度高、重量輕、生物相容性好等特點，預計在預測期內將佔據最大的市場佔有率。這些材料減少了應力屏蔽並促進骨骼更快癒合，使其成為創傷手術中使用的髓內釘的理想選擇。此外，鈦的耐腐蝕性和耐用性確保了植入的長期穩定性，從而增加了外科醫生和醫療保健提供者對其的採用。對微創整形外科手術的需求不斷成長，進一步增強了該領域在市場上的主導地位。

在預計預測期內，門診手術中心 (ASC) 部分將以最高的複合年成長率成長。

預計門診手術中心 (ASC) 部門在預測期內將呈現最高的成長率。 ASC 的成本效益和當日手術能力使其成為醫院護理的一種有吸引力的替代方案。由於恢復時間更快、住院時間更短，人們對門診整形外科手術的偏好增加，推動了 ASC 的成長。此外，微創技術的進步和當日手術的優惠報銷計劃正在加速髓內釘在 ASC 中的應用，有助於市場快速擴張。

比最大的地區

預計預測期內北美地區將佔據最大的市場佔有率。發達的醫療基礎設施、先進整形外科植入的廣泛採用以及老年人骨折發病率的不斷上升，共同構成了該地區的優勢。市場領導參與企業的出現和整形外科創傷護理領域的持續進步進一步鞏固了北美的地位。此外，優惠的報銷政策和不斷增加的醫療支出也支持了市場的成長。

複合年成長率最高的地區

預計預測期內亞太地區將呈現最高的複合年成長率。該地區的快速成長是由於老年人口的增加、骨質疏鬆症患者數量的增加以及人們對先進創傷治療的認知的不斷提高。印度、中國和日本等國家的醫療保健基礎設施不斷擴大以及醫療旅遊業的興起進一步推動了市場的成長。政府支持負擔得起的整形外科治療和增加對醫療設備製造的投資的舉措正在提升該地區的潛力。隨著醫療保健機會的改善，髓內釘的需求預計將大幅增加。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球髓內釘市場依產品類型分類

  • 介紹
  • 股骨髓內釘
  • 脛骨髓內釘
  • 肱骨髓內釘
  • 特別指甲

6. 全球髓內釘市場（依材料）

  • 介紹
  • 防鏽的
  • 鈦合金

7. 全球髓內釘市場依年齡層分類

  • 介紹
  • 孩子們
  • 成人
    • 青年（18-45歲）
    • 中年（46-65歲）
    • 老年人（65歲以上）

8. 全球髓內釘市場（依骨折類型）

  • 介紹
  • 股骨骨折
    • 股骨近端骨折
    • 股骨幹骨折
    • 股骨遠端骨折
  • 脛骨骨折
    • 脛骨近端骨折
    • 脛骨幹骨折
    • 遠端脛骨（pilon）骨折
  • 肱骨骨折
    • 肱骨近端骨折
    • 肱骨幹骨折
    • 肱骨遠端骨折

9. 全球髓內釘市場按分銷管道分類

  • 介紹
  • 直接銷售
  • 分銷商和零售商
  • 網上銷售

第 10 章全球髓內釘市場（依最終用戶）

  • 介紹
  • 醫院
  • 門診手術中心（ASC）
  • 整形外科門診

第 11 章 全球髓內釘市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Stryker Corporation
  • DePuy Synthes（Johnson & Johnson）
  • Zimmer Biomet
  • Smith+Nephew
  • Medtronic plc
  • B. Braun Melsungen AG
  • Orthofix Medical Inc.
  • Wright Medical Group NV
  • Orthopaedic Implant Company
  • Micromed Medizintechnik GmbH
  • GPC Medical Ltd.
  • MEDIN as
  • Pega Medical Inc.
  • Bioimpianti
  • IMECO SA
  • CarboFix Orthopedics Ltd
  • AAP Implantate AG
  • Mizuho OSI, Inc.
Product Code: SMRC28758

According to Stratistics MRC, the Global Intramedullary Nails Market is accounted for $767.3 million in 2024 and is expected to reach $1138.7 million by 2030 growing at a CAGR of 6.8% during the forecast period. Intramedullary nails are orthopedic implants used to stabilize bone fractures. Inserted into the medullary canal (hollow center) of a bone, they provide internal fixation, aligning and supporting the bone fragments during healing. Commonly used for femur, tibia, and humerus fractures, these nails come in various designs and materials (titanium, stainless steel) to suit different fracture types and patient needs. They enable early mobilization and reduce the need for external fixation.

According to the World Health Organization (WHO), road traffic injuries cause a substantial burden of disability and mortality globally, with an estimated 1.19 million deaths annually.

Market Dynamics:

Driver:

Aging population and osteoporosis

The aging global population, particularly individuals over 60, is a key driver for the intramedullary nails market. Conditions such as osteoporosis increase susceptibility to fractures, necessitating advanced orthopedic solutions. With projections indicating that the elderly population will reach 2.1 billion by 2050, the demand for intramedullary nails is expected to grow significantly. These devices provide effective fracture management, enabling faster recovery and improved mobility, which are critical for elderly patient.

Restraint:

High cost of implants

The high cost of intramedullary nails presents a significant barrier to market growth, particularly in developing regions. These implants can be prohibitively expensive for many patients despite their effectiveness, limiting access to potentially life-saving procedures. The impact extends to healthcare providers and facilities, leading to longer recovery periods and worse patient outcomes in cases where cost prevents optimal treatment.

Opportunity:

Development customized intramedullary nails

Technological advancements in design and materials, including biodegradable nails, smart nails with integrated sensors, and improved locking mechanisms, are enhancing treatment efficacy and expanding the range of conditions that can be effectively treated. Companies focusing on research and development to bring innovative products to market can differentiate themselves and capture larger market share.

Threat:

Changes in healthcare reimbursement policies

Limited reimbursement can reduce procedure volumes and hinder market expansion, particularly in regions with constrained healthcare budgets. Inadequate reimbursement rates or restrictions on coverage for intramedullary nail procedures create financial barriers for patients and healthcare providers. Socioeconomic disparities, including disparities in access to healthcare, education, and resources, can influence the demand for orthopedic treatments.

Covid-19 Impact:

The pandemic significantly impacted the intramedullary nails market, with a 44.6% decline in surgical procedure volumes during peak COVID-19 compared to pre-pandemic levels. Elective surgeries were postponed or cancelled, creating substantial backlogs. Although procedure volumes recovered to 85.8% of pre-pandemic levels in the post-peak period, the expected surge from clearing backlogs has yet to materialize.

The titanium alloy segment is expected to be the largest during the forecast period

The titanium alloy segment is expected to account for the largest market share during the forecast period due to their high strength, lightweight properties, and excellent biocompatibility. These materials reduce stress shielding and promote faster bone healing, making them ideal for intramedullary nails used in trauma surgeries. Additionally, titanium's corrosion resistance and durability ensure long-term implant stability, increasing its adoption among surgeons and healthcare providers. Growing demand for minimally invasive orthopedic procedures further boosts the segment's dominance in the market.

The ambulatory surgical centers (ASCs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centers (ASCs) segment is predicted to witness the highest growth rate. ASCs offer cost-effective, same-day surgical procedures, making them an attractive alternative to hospital-based treatments. The increasing preference for outpatient orthopedic surgeries, driven by shorter recovery times and reduced hospital stays, fuels the growth of ASCs. Additionally, advancements in minimally invasive techniques and favorable reimbursement policies for day-care procedures enhance the adoption of intramedullary nails in ASCs, driving their rapid market expansion.

Region with largest share:

During the forecast period, North America region is expected to hold the largest market share. Factors such as a well-established healthcare infrastructure, high adoption of advanced orthopedic implants, and rising fracture cases among the elderly contribute to the region's dominance. The presence of leading market players and continuous advancements in orthopedic trauma care further strengthen North America's position. Additionally, favorable reimbursement policies and increasing healthcare expenditures support market growth.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The region's rapid growth is driven by a rising geriatric population, increasing cases of osteoporosis, and growing awareness about advanced trauma care. Expanding healthcare infrastructure, coupled with rising medical tourism in countries like India, China, and Japan, further accelerates market growth. Government initiatives supporting affordable orthopedic treatments and increasing investments in medical device manufacturing enhance the region's potential. As healthcare accessibility improves, the demand for intramedullary nails is expected to surge significantly.

Key players in the market

Some of the key players in Intramedullary Nails Market include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Smith+Nephew, Medtronic plc, B. Braun Melsungen AG, Orthofix Medical Inc., Wright Medical Group N.V., Orthopaedic Implant Company, Micromed Medizintechnik GmbH, GPC Medical Ltd., MEDIN a.s., Pega Medical Inc., Bioimpianti, IMECO S.A., CarboFix Orthopedics Ltd, AAP Implantate AG and Mizuho OSI, Inc.

Key Developments:

In February 2024, Smith+Nephew, the global medical technology company, announces the premiere of its newly acquired CARTIHEAL* AGILI-C* Cartilage Repair Implant alongside the REGENETEN* Bioinductive Implant at the AAOS Annual Meeting, demonstrating its leadership with products that enable biological healing for Sports Medicine. Backed by impressive clinical evidence, both technologies are transforming the way healthcare professionals treat soft tissue repair and helping improve patient outcomes versus the current standard of care.

In January 2024, Stryker announced that it expanded its Gamma4 hip fracture nailing system by adding an intermediate nail. The latest expansion received FDA 510(k) clearance in June 2023. Since its 2022 launch, Gamma4 has been used in more than 19,000 cases across more than 850 facilities. Kalamazoo, Michigan-based Stryker now incorporates the RC Lag screw and an anti-rotation clip with sleeve components in the Gamma4.

Product Types Covered:

  • Femoral Intramedullary Nails
  • Tibial Intramedullary Nails
  • Humeral Intramedullary Nails
  • Specialty Nails

Material Types Covered:

  • Stainless Steel
  • Titanium Alloy

Age Groups Covered:

  • Pediatrics
  • Adults

Fracture Types Covered:

  • Femoral Fractures
  • Tibial Fractures
  • Humeral Fractures

Distribution Channels Covered:

  • Direct Sales
  • Distributors & Retailers
  • Online Sales

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Orthopedic Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intramedullary Nails Market, By Product Type

  • 5.1 Introduction
  • 5.2 Femoral Intramedullary Nails
  • 5.3 Tibial Intramedullary Nails
  • 5.4 Humeral Intramedullary Nails
  • 5.5 Specialty Nails

6 Global Intramedullary Nails Market, By Material Type

  • 6.1 Introduction
  • 6.2 Stainless Steel
  • 6.3 Titanium Alloy

7 Global Intramedullary Nails Market, By Age Group

  • 7.1 Introduction
  • 7.2 Pediatrics
  • 7.3 Adults
    • 7.3.1 Young Adults (18-45)
    • 7.3.2 Middle-aged (46-65)
    • 7.3.3 Geriatric (65+)

8 Global Intramedullary Nails Market, By Fracture Type

  • 8.1 Introduction
  • 8.2 Femoral Fractures
    • 8.2.1 Proximal Femoral Fractures
    • 8.2.2 Femoral Shaft Fractures
    • 8.2.3 Distal Femoral Fractures
  • 8.3 Tibial Fractures
    • 8.3.1 Proximal Tibial Fractures
    • 8.3.2 Tibial Shaft Fractures
    • 8.3.3 Distal Tibial (Pilon) Fractures
  • 8.4 Humeral Fractures
    • 8.4.1 Proximal Humeral Fractures
    • 8.4.2 Humeral Shaft Fractures
    • 8.4.3 Distal Humeral Fractures

9 Global Intramedullary Nails Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Sales
  • 9.3 Distributors & Retailers
  • 9.4 Online Sales

10 Global Intramedullary Nails Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgical Centers (ASCs)
  • 10.4 Specialty Orthopedic Clinics

11 Global Intramedullary Nails Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Stryker Corporation
  • 13.2 DePuy Synthes (Johnson & Johnson)
  • 13.3 Zimmer Biomet
  • 13.4 Smith+Nephew
  • 13.5 Medtronic plc
  • 13.6 B. Braun Melsungen AG
  • 13.7 Orthofix Medical Inc.
  • 13.8 Wright Medical Group N.V.
  • 13.9 Orthopaedic Implant Company
  • 13.10 Micromed Medizintechnik GmbH
  • 13.11 GPC Medical Ltd.
  • 13.12 MEDIN a.s.
  • 13.13 Pega Medical Inc.
  • 13.14 Bioimpianti
  • 13.15 IMECO S.A.
  • 13.16 CarboFix Orthopedics Ltd
  • 13.17 AAP Implantate AG
  • 13.18 Mizuho OSI, Inc.

List of Tables

  • Table 1 Global Intramedullary Nails Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Intramedullary Nails Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Intramedullary Nails Market Outlook, By Femoral Intramedullary Nails (2022-2030) ($MN)
  • Table 4 Global Intramedullary Nails Market Outlook, By Tibial Intramedullary Nails (2022-2030) ($MN)
  • Table 5 Global Intramedullary Nails Market Outlook, By Humeral Intramedullary Nails (2022-2030) ($MN)
  • Table 6 Global Intramedullary Nails Market Outlook, By Specialty Nails (2022-2030) ($MN)
  • Table 7 Global Intramedullary Nails Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 8 Global Intramedullary Nails Market Outlook, By Stainless Steel (2022-2030) ($MN)
  • Table 9 Global Intramedullary Nails Market Outlook, By Titanium Alloy (2022-2030) ($MN)
  • Table 10 Global Intramedullary Nails Market Outlook, By Age Group (2022-2030) ($MN)
  • Table 11 Global Intramedullary Nails Market Outlook, By Pediatrics (2022-2030) ($MN)
  • Table 12 Global Intramedullary Nails Market Outlook, By Adults (2022-2030) ($MN)
  • Table 13 Global Intramedullary Nails Market Outlook, By Young Adults (18-45) (2022-2030) ($MN)
  • Table 14 Global Intramedullary Nails Market Outlook, By Middle-aged (46-65) (2022-2030) ($MN)
  • Table 15 Global Intramedullary Nails Market Outlook, By Geriatric (65+) (2022-2030) ($MN)
  • Table 16 Global Intramedullary Nails Market Outlook, By Fracture Type (2022-2030) ($MN)
  • Table 17 Global Intramedullary Nails Market Outlook, By Femoral Fractures (2022-2030) ($MN)
  • Table 18 Global Intramedullary Nails Market Outlook, By Proximal Femoral Fractures (2022-2030) ($MN)
  • Table 19 Global Intramedullary Nails Market Outlook, By Femoral Shaft Fractures (2022-2030) ($MN)
  • Table 20 Global Intramedullary Nails Market Outlook, By Distal Femoral Fractures (2022-2030) ($MN)
  • Table 21 Global Intramedullary Nails Market Outlook, By Tibial Fractures (2022-2030) ($MN)
  • Table 22 Global Intramedullary Nails Market Outlook, By Proximal Tibial Fractures (2022-2030) ($MN)
  • Table 23 Global Intramedullary Nails Market Outlook, By Tibial Shaft Fractures (2022-2030) ($MN)
  • Table 24 Global Intramedullary Nails Market Outlook, By Distal Tibial (Pilon) Fractures (2022-2030) ($MN)
  • Table 25 Global Intramedullary Nails Market Outlook, By Humeral Fractures (2022-2030) ($MN)
  • Table 26 Global Intramedullary Nails Market Outlook, By Proximal Humeral Fractures (2022-2030) ($MN)
  • Table 27 Global Intramedullary Nails Market Outlook, By Humeral Shaft Fractures (2022-2030) ($MN)
  • Table 28 Global Intramedullary Nails Market Outlook, By Distal Humeral Fractures (2022-2030) ($MN)
  • Table 29 Global Intramedullary Nails Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 30 Global Intramedullary Nails Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 31 Global Intramedullary Nails Market Outlook, By Distributors & Retailers (2022-2030) ($MN)
  • Table 32 Global Intramedullary Nails Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 33 Global Intramedullary Nails Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 Global Intramedullary Nails Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 35 Global Intramedullary Nails Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 36 Global Intramedullary Nails Market Outlook, By Specialty Orthopedic Clinics (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.